These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 29331721)

  • 1. Understanding protein-drug interactions using ion mobility-mass spectrometry.
    Eyers CE; Vonderach M; Ferries S; Jeacock K; Eyers PA
    Curr Opin Chem Biol; 2018 Feb; 42():167-176. PubMed ID: 29331721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique insights to intrinsically disordered proteins provided by ion mobility mass spectrometry.
    Stuchfield D; Barran P
    Curr Opin Chem Biol; 2018 Feb; 42():177-185. PubMed ID: 29428839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ion mobility-mass spectrometry as a tool to investigate protein-ligand interactions.
    Göth M; Pagel K
    Anal Bioanal Chem; 2017 Jul; 409(18):4305-4310. PubMed ID: 28500372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isomeric and Conformational Analysis of Small Drug and Drug-Like Molecules by Ion Mobility-Mass Spectrometry (IM-MS).
    Phillips ST; Dodds JN; May JC; McLean JA
    Methods Mol Biol; 2019; 1939():161-178. PubMed ID: 30848461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Use of Mass Spectrometry to Examine IDPs: Unique Insights and Caveats.
    Stuchfield D; France AP; Migas LG; Thalhammer A; Bremer A; Bellina B; Barran PE
    Methods Enzymol; 2018; 611():459-502. PubMed ID: 30471696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The application of ion-mobility mass spectrometry for structure/function investigation of protein complexes.
    Ben-Nissan G; Sharon M
    Curr Opin Chem Biol; 2018 Feb; 42():25-33. PubMed ID: 29128665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural mass spectrometry decodes domain interaction and dynamics of the full-length Human Histone Deacetylase 2.
    Soloviev Z; Bullock JMA; James JMB; Sauerwein AC; Nettleship JE; Owens RJ; Hansen DF; Topf M; Thalassinos K
    Biochim Biophys Acta Proteins Proteom; 2022 Mar; 1870(3):140759. PubMed ID: 35051665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ion mobility in the pharmaceutical industry: an established biophysical technique or still niche?
    Campuzano ID; Lippens JL
    Curr Opin Chem Biol; 2018 Feb; 42():147-159. PubMed ID: 29306688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analyzing Protein Architectures and Protein-Ligand Complexes by Integrative Structural Mass Spectrometry.
    Ahdash Z; Lau AM; Martens C; Politis A
    J Vis Exp; 2018 Oct; (140):. PubMed ID: 30371663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subresidue-Resolution Footprinting of Ligand-Protein Interactions by Carbene Chemistry and Ion Mobility-Mass Spectrometry.
    Lu G; Xu X; Li G; Sun H; Wang N; Zhu Y; Wan N; Shi Y; Wang G; Li L; Hao H; Ye H
    Anal Chem; 2020 Jan; 92(1):947-956. PubMed ID: 31769969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ion Mobility Mass Spectrometry Development and Applications.
    Sun J; Wang Z; Yang C
    Crit Rev Anal Chem; 2024; 54(7):1917-1924. PubMed ID: 36325979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ion mobility coupled to native mass spectrometry as a relevant tool to investigate extremely small ligand-induced conformational changes.
    Stojko J; Fieulaine S; Petiot-Bécard S; Van Dorsselaer A; Meinnel T; Giglione C; Cianférani S
    Analyst; 2015 Nov; 140(21):7234-45. PubMed ID: 26401526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in ion mobility-mass spectrometry for improved structural characterization of glycans and glycoconjugates.
    Chen Z; Glover MS; Li L
    Curr Opin Chem Biol; 2018 Feb; 42():1-8. PubMed ID: 29080446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ion Mobility-Mass Spectrometry to Evaluate the Effects of Protein Modification or Small Molecule Binding on Protein Dynamics.
    Tomlinson LJ; Eyers CE
    Methods Mol Biol; 2020; 2084():179-190. PubMed ID: 31729661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of native mass spectrometry in studying intrinsically disordered proteins: A special focus on neurodegenerative diseases.
    Mitra G
    Biochim Biophys Acta Proteins Proteom; 2019 Nov; 1867(11):140260. PubMed ID: 31382021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gas-phase conformations of intrinsically disordered proteins and their complexes with ligands: Kinetically trapped states during transfer from solution to the gas phase.
    Han JY; Choi TS; Heo CE; Son MK; Kim HI
    Mass Spectrom Rev; 2019 Nov; 38(6):483-500. PubMed ID: 31021441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliable Tracking In-Solution Protein Unfolding via Ultrafast Thermal Unfolding/Ion Mobility-Mass Spectrometry.
    Li G; Zheng S; Chen Y; Hou Z; Huang G
    Anal Chem; 2018 Jul; 90(13):7997-8001. PubMed ID: 29894165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Analytical Perspective on Protein Analysis and Discovery Proteomics by Ion Mobility-Mass Spectrometry.
    Vissers JPC; McCullagh M
    Methods Mol Biol; 2020; 2084():161-178. PubMed ID: 31729660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ambient surface mass spectrometry-ion mobility spectrometry of intact proteins.
    Griffiths RL; Kocurek KI; Cooper HJ
    Curr Opin Chem Biol; 2018 Feb; 42():67-75. PubMed ID: 29166625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large-Scale Structural Characterization of Drug and Drug-Like Compounds by High-Throughput Ion Mobility-Mass Spectrometry.
    Hines KM; Ross DH; Davidson KL; Bush MF; Xu L
    Anal Chem; 2017 Sep; 89(17):9023-9030. PubMed ID: 28764324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.